Navigation Links
Bioniche Reports Fiscal 2008 First Quarter
Date:11/9/2007

rity of these costs can be attributed to the ongoing Phase III clinical program in bladder cancer and expenditures on the E. coli O157:H7 development program.

The basic net loss per share for the first quarter of Fiscal 2008 was ($0.06), compared to a net loss per share of ($0.07) recorded in the same period last year.

Annual Meeting Highlights

At the Company's Annual and Special Meeting of Shareholders yesterday afternoon in Toronto, Ontario, the Company provided an update on its Phase III clinical program with Urocidin in bladder cancer and its E. coli O157:H7 vaccine program. In the first Phase III trial involving refractory bladder cancer patients treated with Urocidin, it was reported that the Data Safety Monitoring Committee is satisfied with the progress of the trial and that recruitment of the 105 patients should be completed by mid-2008. With its E. coli O157:H7 vaccine, Bioniche is in the process of building industry awareness about this bacterium and in support of sales to high profile early adopters.

About Bioniche Life Sciences Inc.

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 195 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health. For more information, please visit http://www.Bioniche.com.

Except for historical information, this news release may contain forward-looking statements that reflect the Company's current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause, but ar
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Bioniche Responds to Australian Equine Influenza Outbreak
2. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
3. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
4. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
5. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
6. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
8. Haemacure Reports Third Quarter 2007 Results
9. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. MDS Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 26, 2015 Pacific Medical LLC, the ... to be featured on Innovations with Ed Begley Jr, ... 2015. The episode will repeat on local cable ... the Pacific Medical home page at: http://www.pacificmedicalsupply.com . ... it is reassuring to trust the integrity of the ...
(Date:3/26/2015)... On March 5, 2015, Portland Trail ... for the season with a torn Achilles tendon in ... Blazers were competing against Dallas, and was confirmed via ... Silva, M.D., who has treated many professional athletes, voiced ... could be prevented. , "Part of the problem ...
(Date:3/26/2015)... 26, 2015 In the key developed markets, ... 2013 and is set to decrease through 2020 at a ... growth is expected up to 2017 at a 2.6% CAGR ... be owing to the surging penetration of fixed-dose combination drugs ... Plus, Valturna, Benicar HCT, and Tekamlo), a hike in the ...
(Date:3/26/2015)... In preparation for the 2016 United States Presidential ... Becic, has issued “report cards” for potential candidates ... as well as their promotion of health and fitness ... Cruz, who has officially announced his candidacy for the ... have shown interest in running for office. This report ...
(Date:3/26/2015)... With the rapidly growing healthcare market ... their care, its not just doctors who are now ... background want a piece of the action. HealthSource Chiropractic ... increase in franchises purchased by people with no health ... Chiropractic? , Chiropractic is an exploding $12.7 billion dollar ...
Breaking Medicine News(10 mins):Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 2Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 4Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 3Health News:HealthSource Chiropractic Franchise Expands National Footprint as Investors Buy In 2Health News:HealthSource Chiropractic Franchise Expands National Footprint as Investors Buy In 3
... Patients with normal left ventricular function who undergo ... coronary intervention (PCI) with drug-eluting stents (DES) had ... the multicenter, retrospective study are reported in the ... a journal published by Wiley-Blackwell on behalf ...
... In the war between drugs and drug-resistant diseases, is ... diseases a big competitive advantage?, asks a research paper ... the National Academy of Sciences. The paper argues ... managing the evolution and slowing the spread of drug-resistant ...
... , WEDNESDAY, June 22 (HealthDay News) -- A poor "gut sense" ... a new study suggests. Researchers had 71 ninth graders enrolled ... their innate sense of numbers, such as asking them to guess ... actually count them. Researchers also divided the students into four ...
... Hepatocellular carcinoma is the most common cancer to strike ... sub-Saharan Africa and Southeast Asia, are diagnosed with it ... A big obstacle to treatment of liver cancer ... ultrasound, CT and MRI scans, spot tumors only when ...
... for patients in a medical intensive care unit in a ... tracking thousands of important details, some of which could get ... copilot to make sure nothing slips by. A new ... care unit could use a copilot, too. The mortality rate ...
... water. What happens? As soon as the soap hits the water, ... Now, what if the sink was a cancer cell, the globs ... potential drug? According to new research from the University of Toronto ... membrane (a.k.a., the edge of the sink)and make the cancer cell ...
Cached Medicine News:Health News:Positive results for unprotected left main coronary artery PCI with drug-eluting stents 2Health News:Slowing the spread of drug-resistant diseases is goal of new research area 2Health News:Slowing the spread of drug-resistant diseases is goal of new research area 3Health News:Slowing the spread of drug-resistant diseases is goal of new research area 4Health News:Math Learning Disabilities Linked to Poor 'Gut Sense' of Numbers 2Health News:Gold nanoparticles help earlier diagnosis of liver cancer 2Health News:Nudging doctors in intensive care unit reduces deaths 2Health News:Nudging doctors in intensive care unit reduces deaths 3Health News:Molecular glue sticks it to cancer 2
(Date:3/26/2015)... , March 26, 2015 InfuSystem Holdings, Inc. ... and related services for the healthcare industry in ... , announced today it has secured a new $45.0 million ... its previous $36.5 million credit facility with its prior lender ... entered into the new five-year senior secured credit agreement comprised ...
(Date:3/26/2015)... , 26. März 2015  Die National ... vom 1. April 2015 an Zulassungsanträge für Domainnamen ... Apotheken annehmen. Seit dem Start des .Pharmacy ... über 275 .pharmacy-Domainnamen zugelassen, die für die ... beantragt wurden. Die NABP startete .pharmacy TLD, ...
(Date:3/26/2015)... Editor Note: For more information about ... Investor-Edge has initiated coverage on the following equities: Mylan ... SLXP ), Hospira Inc. (NYSE: HSP ), ... (NASDAQ: AKRX ). Free research report on Mylan ... markets declined on Wednesday, March 25, 2015, as the ...
Breaking Medicine Technology:InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4Alle abgebenden Apotheken berechtigt, um ab dem 1. April 2015 .Pharmacy-Domainnamen zu beantragen 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 3Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 4Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 5
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... company completed its previously announced acquisition of AB Sanitas ... Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ... and markets a broad range of pharmaceutical products primarily ...
... Medical Inc. (NYSE: SMA ), a leading ... implants, surgical instruments, and sterilization cases and trays, announced ... of Olsen Medical. Olsen Medical is a ... of electrosurgical instruments and accessories. It manufactures a full ...
Cached Medicine Technology:Symmetry Medical Closes Olsen Medical Acquisition 2
Aaron Burr II with disposable 1mm burr for corneal rust ring removal and a diamond burr tip for polishing the pterygium bed after surgical removal and for lid margin lesions....
Algerbrush II corneal rust ring remover battery powered...
Non-Illuminated Trial Lens Set with lenses mounted in plastic frames....
Plus cylinders only trial lens set....
Medicine Products: